Home › Leukemie

Leukemie klinische studies rekruteren in de VS

102 studies voor Leukemie rekruteren deelnemers op locaties doorheen de Verenigde Staten.

Steden met de meeste studies

• Houston, TX28 studies
• Boston, MA25 studies
• New York City, NY19 studies
• Los Angeles, CA16 studies
• Chicago, IL16 studies
• Durham, NC13 studies
• Columbus, OH12 studies
• Nashville, TN12 studies
• Baldwin Park, CA12 studies
• Philadelphia, PA12 studies
• Milwaukee, WI11 studies
• Atlanta, GA11 studies
• Seattle, WA11 studies
• Birmingham, AL10 studies
• Aurora, CO10 studies
• Miami, FL9 studies
• Edison, NJ9 studies
• Mountain View, CA9 studies
• Cincinnati, OH9 studies
• Queens, NY8 studies
• New Haven, CT8 studies
• Dallas, TX8 studies
• Portland, OR8 studies
• Orange, CA7 studies
• Denver, CO7 studies
• Clifton, NJ7 studies
• Buffalo, NY7 studies
• Washington, DC7 studies
• Tampa, FL7 studies
• Omaha, NE6 studies
• Cedar Rapids, IA6 studies
• Cleveland, OH5 studies
• Charlottesville, VA5 studies
• Charlotte, NC5 studies
• Rochester, MN5 studies
• Memphis, TN5 studies
• Ann Arbor, MI5 studies
• Baltimore, MD5 studies
• San Diego, CA5 studies
• St. Louis, MO4 studies

Per staat

• Alabama10 studies
• Arizona7 studies
• Californië28 studies
• Colorado15 studies
• Connecticut11 studies
• Florida17 studies
• Georgia13 studies
• Illinois17 studies
• Indiana4 studies
• Iowa7 studies
• Kansas5 studies
• Kentucky6 studies
• Louisiana3 studies
• Maine3 studies
• Maryland11 studies
• Massachusetts28 studies
• Michigan8 studies
• Minnesota9 studies
• Missouri6 studies
• Nebraska6 studies
• New Jersey15 studies
• New Mexico3 studies
• New York26 studies
• North Carolina20 studies
• Ohio26 studies
• Oklahoma4 studies
• Oregon9 studies
• Pennsylvania15 studies
• Rhode Island4 studies
• South Carolina6 studies
• Tennessee14 studies
• Texas31 studies
• Utah4 studies
• Vermont4 studies
• Virginia7 studies
• Washington11 studies
• Wisconsin13 studies

Recent bijgewerkte studies

Officiële studietekst (Engels)

Van ClinicalTrials.gov, gegevens opgehaald op 2 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.